Epidemiology of Cannabis Use Among Middle-Aged and Older Adults in the United States
Livne, O.; Stohl, M.; Gilman, J.; Goldberg, T.; Wall, M.; Hasin, D. S.
Show abstract
ImportanceStudies report disproportionate increases in cannabis use among middle-aged (50-64) and older (65+) U.S. adults, groups particularly vulnerable to its adverse effects. However, national data on attitudes towards cannabis use and legalization, as well as prevalences of key cannabis-related behaviors are lacking for these groups. ObjectiveTo present national prevalences of past-year any cannabis use, medical use, consumption methods, and other important use-related behaviors, and attitudes toward use, as well as associations of such behaviors and attitudes to cannabis use among U.S. adults ages 50 and older. DesignCross-sectional data from the Health and Retirement Study (HRS) were used to calculate weighted prevalences for all cannabis measures by primary age groups (50-64, [≥]65) as well as two specified older age groups (65-74, [≥]75) and sex. Associations between sociodemographics and cannabis use were evaluated using multivariable logistic regression. Main Outcomes and MeasuresSelf-reported past-year cannabis use (outcome), consumption methods, medical use and health conditions for which cannabis was used, prescriptions by healthcare providers, current and past perception of acceptability, perceptions of risk, and attitudes toward legalization (exposures). Covariates included sex, race/ethnicity, household income, and employment status. Setting and ParticipantsHRS participants who completed the 2018 cannabis use experimental module (n=1,324). ResultsPast year cannabis use was reported by 18.5% (SE=2.17) and 5.9% (SE=1.19) of middle-age and older adults, respectively in the U.S. In both groups, a majority of individuals consumed cannabis exclusively by smoking. Approximately 25% of middle-aged adults and 20% of older adults used cannabis for medical purposes, with [~]20% in both groups receiving a prescription or recommendation for medical use from a healthcare provider. Over 75% of individuals in both age groups viewed medical use of cannabis as acceptable, and older adults were more likely to view cannabis as a gateway drug and to support restrictions of cannabis laws. Conclusions and RelevanceCannabis use among both middle-aged and older U.S. adults is higher than previously reported in state- and national-level studies, with many engaging in cannabis behaviors associated with increased harm. Greater public health and clinical efforts are needed for tailored prevention and intervention strategies.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Changes in injecting versus smoking heroin, fentanyl, and methamphetamine among people who inject drugs in San Diego, California, 2020 to 2023 94%
- Agreement between DSM-IV and DSM-5 measures of substance use disorders in a sample of adult substance users 94%
- Fentanyl, Heroin, and Methamphetamine-Based Counterfeit Pills Sold at Tourist-Oriented Pharmacies in Mexico: An Ethnographic and Drug Checking Study 94%
Similar papers in this journal
- Polydrug overdose mortality caused by synthetic opioids and stimulants: Current sex- and age- specific trajectories in United States national data for 2018-2024 93%
- Longitudinal Neurocognitive Trajectories in a Large Cohort of Youth Who Use Cannabis: Combining Self-Report and Toxicology 92%
- Δ9-Tetrahydrocannabinol (THC) impairs visual working memory performance 91%
Similar papers in this journal
- Impact of year-long cannabis use for medical symptoms on brain activation during cognitive processes 92%
- Effectiveness of a Text Message Intervention Promoting Seat Belt Use Among Targeted Young Adults: A Randomized Clinical Trial 92%
- Association between social media use and self-reported symptoms of depression in US adults 91%
Similar papers in this journal
- Transitions from smoking to exclusive e-cigarette use, dual use, or stopping nicotine use in ALSPAC and their association with modifiable and sociodemographic factors 94%
- Age-based differences in quantity and frequency of consumption when screening for harmful alcohol use 93%
- Association of Topiramate Prescribed for any Indication with Reduced Alcohol Consumption in Electronic Health Record Data 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.